Search Videos and More
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.Jay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.GENITOURINARY CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship ServicesFEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY
Fox Chase – Temple Urologic Institute’s program is a comprehensive center serving women with pelvic floor disorders such as incontinence and pelvic order prolapse. Our team has extensive training and experience in the diagnosis and treatment of conditions that affect the pelvic organs. We partner closely with you and your primary care physician, OB/GYN, and urologistto ensure you have the highest level of pelvic care.BENIGN PROSTATE HYPERPLASIA
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted regional leader in treating all types of urologic conditions. Our physicians are available to assist with diagnosing and treating benign prostate hyperplasia, including seeing patients for whom other medical treatments have failed.Fox Chase Cancer Center and Lewis Katz School of Medicine Researchers Identify Where to Target Interventions to Reduce Disparities in Aggressive Prostate Cancer
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black communities with high rates of poverty.Tackling Anything Patients Need Before, During, and After Urologic Surgery
Growing up, Mary Ellen Day was athletic and focused—dreaming that one day, she would become a ‘real’ cheerleader.Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark
Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a Fox Chase – Temple Urologic Institute provider.ENDING THE RELIANCE ON BCG
A Phase III clinical trial for bladder cancer
Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.